SB271046 is a potent, selective and orally active 5-HT6 receptor antagonist with pKi of 8.9, exhibits 200-fold greater selectivity over other 5-HT receptor subtypes.

価格 在庫  
USD 185 In stock
USD 239 In stock
USD 718 In stock

SB271046 化学構造
分子量: 451.99


Quality Control & MSDS




情報 SB271046 is a potent, selective and orally active 5-HT6 receptor antagonist with pKi of 8.9, exhibits 200-fold greater selectivity over other 5-HT receptor subtypes.
目標 5-HT6
IC50 8.92 (pKi) [1]
In vitro試験 SB-271046 also potently displaces [125I]-SB-258585 from rat and pig striatal and human caudate putamen membranes with pKis of 9.02, 8.55 and 8.81, respectively. SB-271046 competitively antagonizes 5-HT-induced stimulation of adenylyl cyclase activity with a pA2 of 8.71. [1] SB-271046 is found to be a competitive antagonist with a pA2 of 8.7 in the functional adenylyl cyclase assay which is in good agreement with its binding affinity. SB-271046 demonstrates no significant inhibitory activity at the major human P450 enzymes. [2]
In vivo試験 SB-271046 produces an increase in seizure threshold over a wide-dose range in the rat maximal electroshock seizure threshold (MEST) test, with a minimum effective dose of 0.1 mg/kg p.o. and maximum effect at 4 hours post-dose. The level of anticonvulsant activity achieves correlated well with the blood concentrations of SB-271046 (EC50 of 0.16 μM) and brain concentrations of 0.01 μM–0.04 μM at Cmax. [1] SB-271046 is moderately brain penetrant (10%), subject to low blood clearance (7.7 mL/min/kg) with a good half-life in rats (4.8 hours), and has excellent oral bioavailability (>80%). [2] SB-271046 produces 3-fold and 2-fold increases in extracellular glutamate levels in both frontal cortex and dorsal hippocampus of rats, respectively, which may be used for the treatment of cognitive and memory dysfunction. [3] SB-271046 (20 mg/kg, orally gavage) 30 min prior to training Wistar rats, is found to reverse significantly the amnesia produced by administering scopolamine (0.8 mg/kg, i.p.) in the 6 hours post-training period. SB-271046 progressively and significantly decreases platform swim angle and escape latencies over the five sequential trials on four consecutive daily sessions compared to vehicle-treated controls in aged rats. SB-271046 also improves task recall as measured by significant increases in the searching of the target quadrant on post-training days 1 and 3. [4] SB-271046 (10 mg/kg, s.c.) produces a significant, tetrodotoxin-dependent, increase in extracellular levels of both glutamate and aspartate within the frontal cortex of rats, reaching maximum values of 375.4% and 215.3% of preinjection values, respectively. [5]

推薦された実験操作 (公開の文献だけ)

キナーゼアッセイ: [1]

Binding assay Radioligand binding is performed on membranes from HeLa cells stably transfected with the human 5-HT6 receptor and striatal tissue from adult rats, adult pigs and human caudate putamen tissues. Membranes are incubated with 1 nM [125I]-SB-258585 or 2 nM [3H]-LSD for 45 min at 37 ℃. Non-specific binding is defined by the inclusion of 10 μM methiothepin and the assay ias terminated by rapid filtration through Whatman GF/B filters.

動物実験: [1]

動物モデル Male Sprague Dawley rats
製剤 1% methyl cellulose in water
投薬量 30 mg/kg
管理 Orally



Download SB271046 SDF
分子量 451.99


CAS No. 209481-20-9
別名 N/A
溶解度 (25°C)
  • DMSO 40 mg/mL
  • 水 <1 mg/mL
  • エタノール <1 mg/mL
保管 2年 -20°C
6月-80°Cin DMSO
化学名 Benzo[b]thiophene-2-sulfonamide, 5-chloro-N-[4-methoxy-3-(1-piperazinyl)phenyl]-3-methyl-




電話番号: +1-832-582-8158 Ext:3月曜日〜金曜日 9:00 AM–5:00 PM (米国中部標準時)


* 必須

Related 5-HT受容体 阻害剤

  • Agomelatine

    Agomelatine is classified as a norepinephrine-dopamine disinhibitor (NDDI) due to its antagonism of the 5-HT2C receptor.

  • Latrepirdine

    Latrepirdine is an antihistamine drug.

  • Asenapine

    Asenapine inhibits adrenergic receptor1, α2A, α2B, α2C) with Ki of 0.25-1.2 nM and also inhibits 5-HT receptor (1A, 1B, 2A, 2B, 2C, 5A, 6, 7) with Ki of 0.03-4.0 nM.

  • Fluoxetine HCl

    Fluoxetine HCl is an antidepressant of the selective serotonin reuptake inhibitor (SSRI)class.

  • Fluvoxamine maleate

    Fluvoxamine maleate is a selective serotonin (5-HT) reuptake inhibitor (SSRI)

  • Granisetron HCl

    Granisetron HCl is a serotonin 5-HT3 receptor antagonist

  • Mosapride Citrate

    Mosapride Citrate is a gastroprokinetic agent that acts as a selective 5HT4 agonist.

  • Ondansetron HCl

    Ondansetron HCl is a serotonin 5-HT3 receptor antagonist.

  • Sumatriptan Succinate

    Sumatriptan Succinate is a triptan sulfa drug containing a sulfonamide group for the treatment of migraine headaches.

  • Tianeptine sodium

    Tianeptine sodium is a selective serotonin reuptake enhancer (SSRE) compound used for treating major depressive episodes.


Tags: SB271046を買う | SB271046供給者 | SB271046を購入する | SB271046費用 | SB271046生産者 | オーダーSB271046 | SB271046代理店